Eurazeo increases stake in VC firm Kurma Partners
Eurazeo is to raise its stake in Kurma Partners, a French venture capital firm specialising in biotechnology and medical innovation, to 70.6 per cent. This transaction coincides with Kurma’s launch of a third investment strategy, Growth Opportunity, to support more mature companies, with late stage clinical or early commercial stage